Skip to content

Category: Uncategorized

Published on

There is growing evidence that women around a lot of endocrine disrupting chemicals at home or in jobs such as cleaners, hairdressers and laboratory workers during pregnancy are more likely to have baby boys with a genital defect called hypospadias (a condition where the opening of the urethra is on the underside of the penis rather than at the tip). From Environmental Health News:

Genital defect in baby boys linked to moms’ chemical exposure

Mothers around a lot of endocrine disrupting chemicals at home or in jobs such as cleaners, hairdressers and laboratory workers during pregnancy are more likely to have baby boys with a genital defect, according to a new study in the south of France.The study adds to mounting evidence that fetal exposure to chemicals that mimic people’s natural hormones may cause hypospadias, a condition where the opening of the urethra is on the underside of the penis rather than at the tip.

French researchers examined more than 600 children in the south of France and found that babies exposed to endocrine disrupting chemicals while their genitals were developing were more likely to suffer from hypospadias. Half the boys had hypospadias and half did not. The risk for those exposed was 68 percent higher than the unexposed boys. The researchers ruled out baby boys with known genetic risks for such defects.

The defect, which can be minor or quite severe depending on how far the opening is from the tip, can lead to problems with urination and, later in life, sexual difficulty....It is one of the most common genital defects in baby boys, and most cases require surgery, often done before they reach two years old. In the United States, an estimated five out of 1,000 boys are born annually with hypospadias, while Europe’s rate is slightly less than two out of 1,000.

The researchers estimated the unborn babies’ exposure by looking at their parents’ jobs and where they lived. Working with hormone disrupting chemicals and living in homes near heavy polluters were both linked to more baby boys having the defect. However, the researchers did say a limit of the study was attempting to estimate fetal exposure to such chemicals.Mothers were most likely to have boys with hypospadias if they worked as a cleaner, hairdresser or beautician.  

Some of the endocrine disrupting chemicals linked to the professions involved in the study were bisphenol-A (BPA), phthalates, polychlorinated compounds, alkylphenolic compounds and organic solvents. Most exposures—78 percent—occurred in the window of development when babies’ genitals are forming.... but detergents, pesticides, and cosmetics accounted for 75 percent of the cases,” the authors wrote in the study published in the European Urology journal this month.

Other possible causes of the birth defect include older, obese mothers, and fertility or hormone treatments during pregnancy, according to the U.S. Centers for Disease Control and Prevention.

This wasn’t the first time scientists have found a link between certain chemicals and hypospadias. Mothers in southeast England who were heavily exposed to endocrine disrupting phthalates on the job were about three times as likely to have a baby boy with hypospadias. Phthalates are used in some cosmetics, fragrances, food packaging and PVC plastics.

Published on

Looks like another procedure is found not to be beneficial and possibly harmful - this time arthroscopic surgery as a treatment for the middle aged or older person with a painful arthritic knee or torn meniscus (the shock absorbing cartilage between the knee bones). The researchers also found that "exercise therapy" had more benefits. From Medical Xpress:

Benefit of knee surgery for middle aged or older patients 'inconsequential', say experts

The benefit of surgery for middle aged or older patients with persistent knee pain is inconsequential and such surgery is potentially harmful, say researchers in a study published in The BMJ this week.Their findings do not support arthroscopic surgery as a treatment for the middle aged or older person with a painful arthritic knee or torn meniscus (the shock absorbing cartilage between the knee bones).

The article is part of The BMJ's Too Much Medicine campaign - to highlight the threat to human health and the waste of resources caused by unnecessary care. Over 700,000 knee arthroscopies (a type of keyhole surgery) are carried out in the USA and 150,000 in the UK each year on middle aged and older adults with persistent knee pain. Yet the evidence for arthroscopic surgery is known to be weak, with all but one published trials showing no added benefit for surgery over control treatment.Despite this, many specialists are convinced of the benefits of surgery.

So researchers based in Denmark and Sweden reviewed the results of 18 studies on the benefits and harms of arthroscopic surgery compared with a variety of control treatments (ranging from placebo surgery to exercise) for middle aged and older people with persistent knee pain.s.

Overall, surgery was associated with a small but significant effect on pain at three and six months (but no longer) compared with control treatments. No significant benefit on physical function was found. A further nine studies reporting on harms found that, although rare, deep vein thrombosis (DVT) was the most frequently reported adverse event, followed by infection, pulmonary embolism (a blockage of the main artery of the lung), and death.

"Interventions that include arthroscopy are associated with a small benefit and with harms," say the authors, and the benefit is "markedly smaller than that seen from exercise therapy." These findings "do not support the practice of arthroscopic surgery as treatment for middle aged or older patients with knee pain with or without signs of osteoarthritis," they conclude.

"It is difficult to support or justify a procedure with the potential for serious harm, even if it is rare, when that procedure offers patients no more benefit than placebo," argues Professor Andy Carr from Oxford University in an accompanying editorial.

 

Published on

A wonderful commentary by Dr. Mandrola about recent research of almost 500,000 UK citizens. Researchers found that just asking the patient several basic questions was a better predictor of 5 year mortality than all sorts of blood tests, measurements, and analyses. The best basic questions were: Is your health excellent, good, average, or poor? Is your walking pace slow, average, or brisk? Along with smoking, those two basic questions were the best predictors of staying alive in the next 5 years. These excerpts are from Medscape:

Health Is Not Complicated—Just Ask the Patient

It turns out predicting health is not so complicated. Nor is it digital at all. For persons of middle age (40 to 70 years), self-reported overall health and walking speed were the best predictors of death in the next 5 years, according to a study published this week in the Lancet.[1]

In an analysis of nearly 500,000 UK citizens followed for 5 years, these two simple questions outperformed 655 measurements of demographics, health, and lifestyle. Is your health excellent, good, average, or poor? Is your walking pace slow, average, or brisk? Along with smoking, those two basic questions, inquiries that hardly require a digital device, were the best predictors of staying alive in the next 5 years.

Pause for a moment here and ponder the beauty of that top-line result. Half a million people followed for 5 years; 655 measures of health, including heart rate, blood pressure, and lab tests, and the best predictors were that simple.

In the 5 years of follow-up, 8532 (1.7%) subjects died. Overall, cancer was the most common cause of death (53% in men; 69% in women). The most common cancer-related cause of death was lung cancer in men (n=546) and breast cancer in women (n=489). Cardiovascular disease was the second leading cause of death (26% in men; 33% in women).

 

There were gender differences in predictors of death. Self-reported health was the strongest predictor of death in men (C index 0.74). In women, a previous cancer diagnosis was the strongest predictor (C index 0.73).Self-reported walking pace was a strong predictor of death in both men and women (C index 0.72 and 0.69, respectively.) For example, a man aged 40 to 52 years who reported a slow walking pace was 3.7 times more likely to die than a similarly aged man who reported a steady walking pace. In a large subset of subjects with no reported health conditions, smoking was the best predictor of mortality.

 

The final, and perhaps niftiest, aspect of this study was that researchers developed an 11 to 13 question risk prediction score, which they then put on an interactive website. Anyone can answer these simple questions and get their health-related age relative to the UK population. The researchers call this age the UK Longevity Explorer (UbbLE) age.

I am drawn to these findings because they emphasize something that is increasingly lost on both doctors and patients. True health is not complicated. And the big picture is still useful.Any experienced clinician will testify that patients know when they are well and when they are not. The finding that self-reported health predicts death urges clinicians, generalists and specialists alike, to ask our patients how they feel about their health.

Then there is the matter of self-reported walking pace. How easy it is to be distracted by digital data. We walk into the exam room to see our patient. He is still. We look at him. We poke and listen to his body. We assess his ECG and other measures. Soon we will review his smartphone metrics and DNA data. Yet we tend to forget the obvious: to move is to be healthy. Drs Ganna and Ingelsson teach us that to move briskly may be healthier.

Published on

Stop drinking soda every day! Research finds that a daily sugar-sweetened beverage habit may increase the risk for non-alcoholic fatty liver disease (NAFLD). Earlier research has already linked daily sugar-sweetened beverages (typically soda) to type 2 diabetes and cardiovascular disease. And try to avoid high-fructose corn syrup in general (found in many highly processed foods) . From Medical Xpress:

Daily sugar-sweetened beverage habit linked to non-alcoholic fatty liver disease

A daily sugar-sweetened beverage habit may increase the risk for non-alcoholic fatty liver disease (NAFLD), researchers from the Jean Mayer USDA Human Nutrition Research Center on Aging (USDA HRNCA) at Tufts University report today in the Journal of Hepatology.

The researchers analyzed 2,634 self-reported dietary questionnaires from mostly Caucasian middle-aged men and women enrolled in the National Heart Lunch and Blood Institute (NHLBI) Framingham Heart Study's Offspring and Third Generation cohorts....The participants underwent a computed tomography (CT) scan to measure the amount of fat in the liver and the authors of the current study used a previously defined cut-point to identify NAFLD. They saw a higher prevalence of NAFLD among people who reported drinking more than one sugar-sweetened beverage per day compared to people who said they drank no sugar-sweetened beverages.

The relationships between sugar-sweetened beverages and NAFLD persisted after the authors accounted for age, sex, body mass index (BMI), and dietary and lifestyle factors such as calorie intake, alcohol, and smoking. In contrast, after accounting for these factors the authors found no association between diet cola and NAFLD.

NAFLD is characterized by an accumulation of fat in the liver cells that is unrelated to alcohol consumption. NAFLD is diagnosed by ultrasounds, CT, MRI, or biopsy, and many of the approximately 25% of Americans with the disease don't experience any symptoms. Being obese or overweight increases the risk for NAFLD and people with NAFLD are at greater risk of developing cardiovascular disease and type 2 diabetes.Sugar-sweetened beverages are a major dietary source of fructose, the sugar that is suspected of increasing risk of NAFLD because of how our bodies process it.

Published on

Textbooks will have to be rewritten with the recent discovery of a system of lymphatic vessels that are a direct link from the immune system to the brain. Amazing that after centuries of studying people, that only now was this system detected (but they are very small and they follow a major blood vessel down into the sinuses). After extensive research,  the researchers determined that these vessels carry both fluid and immune cells from the cerobrospinal fluid, and that they exist in humans. The discovery reinforces findings that immune cells are present even within healthy brains, a notion that was doubted until recently.From Medical Daily:

Discovery Of 'Missing Link' Between Brain And Immune System Could Change How Disease Is Studied

The recent discovery of a "missing link" between the brain and the immune system may lead to a complete revision of biology textbooks. The link, vessels of the lymphatic system that run through the sinuses, were previously unidentified and thought not to exist. However, the true significance of the discovery lies in the potential effects this finding could have on both the study and treatment of neurological diseases such as Alzheimer’s disease and multiple sclerosis.  

The newly discovered "central nervous system lymphatic system vessels" follow a major blood vessel down into the sinuses, an area that has been traditionally difficult to obtain images of. Their presence is causing a stir in the medical world, as the researchers responsible believe the vessels may help to explain current medical mysteries, such as why patients with Alzheimer’s disease have accumulations of large protein plaques in the brain.

The fascinating discovery was made by researchers at the University of Virginia School of Medicine, and a study on the finding is currently available in the online journal Nature....Using a recently developed method, the team mounted the meninges, the membranes covering the brain, on a single slide so that they could be better observed. Only after doing this were they able to notice the brain’s elusive lymphatic vessels.   "It's so close to the blood vessel, you just miss it," Kipnis said. "If you don't know what you're after, you just miss it."

The team believes that the “missing link” between the brain and the immune system could explain why some diseases like Alzheimer’s can cause plaque buildup in the brain. Kipnis believes this plaque may be the result of the meningeal lymphatic vessels not efficiently removing buildup before it reaches the brain. Although scientists are currently not sure what causes cell death and tissue loss in the brains of those with Alzheimer’s, this plaque buildup is believed to play a role.

It’s not just the presence of plaque in the brain that the researchers hope this discovery can shed light on. According to Kipnis, this discovery could completely change the way we perceive the neuro-immune interaction.“We believe that for every neurological disease that has an immune component to it, these vessels may play a major role,” Kipnis said. “Hard to imagine that these vessels would not be involved in a [neurological] disease with an immune component.”The vessels also appear to look different with age, which has lead the researchers to suggest that they may play a role in the aging process.

 

Maps of the lymphatic system: old (left) and updated to reflect UVA's discovery.   Credit: University of Virginia Health System

Published on

Low levels of vitamin D are associated with low levels of testosterone in healthy middle-aged men. Note that hypovitaminosis D means low levels of vitamin D in the blood, defined by a lab test as "25-hydroxyvitamin D level below 30.0 ng/L. Interestingly, being overweight also seems to lower the testosterone level, and losing weight raises the level, and supplementing with vitamin D may raise the testosterone level in those with low levels (the German study mentioned in the article). And research with mice suggests that there is something about testosterone synthesis that needs vitamin D. From Medscape:

Low Vitamin D Tied to Testosterone Dip in Healthy Men

Low levels of vitamin D are significantly and independently associated with low levels of testosterone in otherwise healthy middle-aged men, according to a study presented at the American Urological Association 2015 Annual Meeting in New Orleans. 

In this new analysis of data from of the World Trade Center CHEST program, blood samples from 824 men were analyzed for various parameters, such as 25-hydroxyvitamin D and total testosterone. Hypovitaminosis D was defined as a 25-hydroxyvitamin D level below 30.0 ng/L.

Level of 25-hydroxyvitamin D were insufficient in 68% of the samples....Total testosterone was higher in men with normal levels of 25-hydroxyvitamin D than in men with lower levels...."subjects with hypovitaminosis D still had significantly lower total testosterone than those with normal total testosterone (P = .019)," Dr McLaughlin and her colleagues report. When levels of 25-hydroxyvitamin D were lower, body mass index was higher than when levels were normal (30.8 vs 29.12 kg/m²; P < .001), waist circumference was greater (41.3 vs 39.8 inches; P < .001), and lipid profiles were less favorable.

In previous studies, testosterone levels were shown to be lower in mice who had the vitamin D receptor genetically deleted, said Dr McLaughlin."This suggests that there is something about testosterone synthesis that needs vitamin D," she explained.

In a small German study of healthy overweight men with a low baseline level of 25-hydroxyvitamin D and testosterone levels at the lower end of the reference range, there was a significant increase in total testosterone levels after 12 months of vitamin D 3000 IU daily (Horm Metab Res. 2011;43:223-225)...the German study was primarily a weight-loss study, and weight loss in and of itself causes increases in testosterone."We see that in patients who undergo bariatric surgery to remove visceral fat," he explained. "Once the weight loss has taken place, their testosterone levels normalize independent of anything else."

Published on

Another good reason to breastfeed. Exposure to pollutants like nitrogen dioxide and airborne particles can cause negative effects on motor and mental development in infants, but a new study says those effects are countered in babies who are breast-fed for at least 4 months by their mothers. Researchers in Spain began monitoring rural, pregnant women in 2006 and analyzed samples from 638 women and their infants at 15 months. They reported that babies who are breast-fed did not suffer from the potentially harmful developmental impact of PM2.5 (pollution particle matter) and NO2 (nitrogen dioxide). From Science Daily:

Breastfeeding protects against environmental pollution

Living in a city with a high level of vehicle traffic or close to a steel works means living with two intense sources of environmental pollution. However, a study conducted by the UPV/EHU researcher Aitana Lertxundi indicates that the harmful effect of PM2.5 pollution particle matter and nitrogen dioxide (NO2) disappears in breastfed babies during the first four months of life. According to the results of the research, breastfeeding plays a protective role in the presence of these two atmospheric pollutants.

Lertxundi's study focusses on the repercussions on motor and mental development during the first years of life caused by exposure to the PM2.5 and NO2 atmospheric pollutants .... "In the fetal phase the central nervous system is being formed and lacks sufficient detoxification mechanisms to eliminate the toxins that build up," pointed out Aitana Lertxundi.

The PM2.5 particles measure less than 2.5 micra, in other words, they are four times thinner that a single hair and are suspended in the air. As they are so small they can easily penetrate the body and as they weigh so little they can spread without any difficulty through the air and can move far away from the initial emission source. The composition of these neurotoxic particles depends on the emission sources in the area. The INMA Gipuzkoa area under study has a high presence of neurotoxic particle matter made up of lead, arsenic and manganese from industrial activity and traffic. In comparison with urban averages where the main source of pollution is traffic, the concentration is lower.

One result of the study is that the existence of an inverse relationship has been detected between exposure to pollution particle matter and the motor development of babies. In this respect, the researcher highlights the fact that "these indices display an alteration with respect to the average and, even if they are not worrying, they are significant in that they reveal the relationship existing between air quality and motor development." The analysis of the data also shows that neither the PM2.5 particle matter nor the NO2 exert a harmful effect on babies breastfed on mother's milk for at least four months.

Published on

Finding out that so many of probiotics currently contain traces of gluten is of serious concern to people wishing to avoid gluten in food products, for example those with celiac disease. Too bad the researchers didn't publish the brands.From Science Daily:

Many probiotics are contaminated with traces of gluten

More than half of popular probiotics contain traces of gluten, according to an analysis. Tests on 22 top-selling probiotics revealed that 12 of them (or 55%) had detectable gluten. Gluten is a protein found in wheat, rye, and barley, and patients with celiac disease need to eliminate it from their diet or face pain, bowel symptoms, and an increased risk of cancer.

Probiotics are commonly taken by patients for their theoretical effect in promoting gut health, though evidence of benefits is limited to a few clinical situations. "Many patients with celiac disease take dietary supplements, and probiotics are particularly popular," said Dr. Samantha Nazareth, a gastroenterologist at CUMC and the first author of the study. "We have previously reported that celiac patients who use dietary supplements have more symptoms than non-users, so we decided to test the probiotics for gluten contamination," said Dr. Nazareth.

 Most of the probiotics that tested positive for gluten contained less than 20 parts per million of the protein, and would be considered gluten-free by Food and Drug Administration (FDA) standards. However, four of the brands (18% of the total) contained in excess of that amount.

More than half of the 22 probiotics were labeled gluten-free, but this had no bearing on whether or not traces of gluten were present. Two probiotics that did not meet FDA standards carried the label.It is uncertain whether these trace amounts of gluten could cause symptoms or otherwise harm patients with celiac disease. 

Published on

Finding endocrine disrupting chemicals in 2 out of 10 baby teethers, which are supposedly safe products for babies, is disturbing. Unfortunately the study did not give the manufacturers names. There was even an 11th teether made of natural rubber that was found to leach compounds that were "cytotoxic"(toxic to living cells), but the manufacturer recalled the product before the study results were published. One of the teethers leaching parabens was made of EVA plastic filled with a cooling gel, and the researchers thought the parabens came from the gel used. Note that this study occurred in Europe where the regulations regarding endocrine disrupting chemicals are stricter than in the USA. The researchers themselves suggest that manufacturers should use "green chemistry" when manufacturing products - that is, design products without using problem ingredients right from the start. Problem solved. From Science Daily:

Endocrine disrupting chemicals in baby teethers

In laboratory tests, two out of ten teethers, plastic toys used to sooth babies' teething ache, release endocrine disrupting chemicals. One product contains parabens, which are normally used as preservatives in cosmetics, while the second contains six so-far unidentified endocrine disruptors. 

"The good news is that most of the teethers we analyzed did not contain any endocrine disrupting chemicals. However, the presence of parabens in one of the products is striking because these additives are normally not used in plastic toys," says Dr. Martin Wagner, of the Department Aquatic Ecotoxicology at the Goethe University. The substances detected -- methyl, ethyl and propyl parabens -- can act like natural oestrogen in the body and, in addition, inhibit the effects of androgens such as testosterone. The EU Commission recently banned two parabens in certain baby cosmetics, because of concerns over their health effects.

"Our study shows that plastic toys are a source of undesirable chemicals. Manufacturers, regulatory agencies and scientists should investigate the chemical exposure from plastic toys more thoroughly," Wagner concludes from the study. The additives have only limited benefits for the quality of the product, but can represent a potential health issue. This is especially true for babies and infants, whose development is orchestrated by a delicately balanced hormonal control and who are more susceptible to chemicals exposures than adults.

Published on

Controversy exists over whether healthy people should take statins because of possible side effects. This is another study finding a very elevated risk of new onset diabetes, high risk of diabetes complications, and obesity in statin users. This finding was also significant because the statins were given to healthy people (with no heart disease, diabetes, or severe chronic disease). Risks of diabetes, diabetes complications, and obesity were dose related. Statin users were also paired with similar non-statin users and then followed - thus the only differences between the 2 groups was whether they used statins. The researchers themselves write that when considering risks of statins, people should try for lifestyle changes (lose weight, eat healthy, exercise, stop smoking) rather than just rely on popping a pill. From Medical Xpress:

Strong statin-diabetes link seen in large study of Tricare patients

In a database study of nearly 26,000 beneficiaries of Tricare, the military health system, those taking statin drugs to control their cholesterol were 87 percent more likely to develop diabetes.

The study, reported online April 28, 2015, in the Journal of General Internal Medicine, confirms past findings on the link between the widely prescribed drugs and diabetes risk. But it is among the first to show the connection in a relatively healthy group of people. The study included only people who at baseline were free of heart disease, diabetes, and other severe chronic disease."In our study, statin use was associated with a significantly higher risk of new-onset diabetes, even in a very healthy population," says lead author Dr. Ishak Mansi. 

In the study, statin use was also associated with a "very high risk of diabetes complications," says Mansi. "This was never shown before." Among 3,351 pairs of similar patients—part of the overall study group—those patients on statins were 250 percent more likely than their non-statin-using counterparts to develop diabetes with complications. Statin users were also 14 percent more likely to become overweight or obese after being on the drugs....The study also found that the higher the dose of any of the statins, the greater the risk of diabetes, diabetes complications, and obesity.

A key strength of Mansi's study was the use of a research method known as propensity score matching. Out of the total study population, the researchers chose 3,351 statin users and paired them with non-users who were very similar, at baseline, based on array of 42 health and demographic factors. The only substantial difference, from a research standpoint, was the use of statins. This helped the researchers isolate the effects of the drugs.

On a wider scale, looking at the overall comparison between the study's roughly 22,000 nonusers and 4,000 users, and statistically adjusting for certain factors, the researchers found a similar outcome: Users of statins were more than twice as likely to develop diabetes.The researchers examined patient records for the period between October 2003 and March 2012. About three-quarters of the statin prescriptions in Mansi's data were for simvastatin, sold as Zocor.

"I myself am a firm believer that these medications are very valuable for patients when there are clear and strict indications for them," he says. "But knowing the risks may motivate a patient to quit smoking, rather than swallow a tablet, or to lose weight and exercise. Ideally, it is better to make those lifestyle changes and avoid taking statins if possible."